Skip to main content
. 2022 Mar 18;14(6):1292. doi: 10.3390/nu14061292
AD Alzheimer’s disease
AMPA α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid
CNS central nervous system
CSF cerebrospinal fluid
GAT-2 GABA transporter (SLC6A13)
MRS Magnetic resonance spectroscopy
NMDA N-methyl-D-aspartate
TauT taurine transporter (SLC6A6)
VRAC volume-regulated anion channel